- Home
- GLMD vs INM Comparison
GLMD vs INM Comparison
Compare GLMD & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLMD
- INM
- Stock Information
- Founded
- GLMD 2000
- INM 1981
- Country
- GLMD Israel
- INM Canada
- Employees
- GLMD N/A
- INM N/A
- Industry
- GLMD Biotechnology: Pharmaceutical Preparations
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- GLMD Health Care
- INM Health Care
- Exchange
- GLMD Nasdaq
- INM Nasdaq
- Market Cap
- GLMD 3.0M
- INM 3.2M
- IPO Year
- GLMD 2014
- INM N/A
- Fundamental
- Price
- GLMD $1.81
- INM $3.33
- Analyst Decision
- GLMD Hold
- INM
- Analyst Count
- GLMD 1
- INM 0
- Target Price
- GLMD N/A
- INM N/A
- AVG Volume (30 Days)
- GLMD 364.3K
- INM 9.5M
- Earning Date
- GLMD 05-22-2025
- INM 05-12-2025
- Dividend Yield
- GLMD N/A
- INM N/A
- EPS Growth
- GLMD N/A
- INM N/A
- EPS
- GLMD N/A
- INM N/A
- Revenue
- GLMD N/A
- INM $4,920,990.00
- Revenue This Year
- GLMD N/A
- INM N/A
- Revenue Next Year
- GLMD N/A
- INM N/A
- P/E Ratio
- GLMD N/A
- INM N/A
- Revenue Growth
- GLMD N/A
- INM N/A
- 52 Week Low
- GLMD $1.15
- INM $1.72
- 52 Week High
- GLMD $23.80
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- GLMD 61.13
- INM 59.24
- Support Level
- GLMD $1.63
- INM $2.26
- Resistance Level
- GLMD $1.94
- INM $5.50
- Average True Range (ATR)
- GLMD 0.12
- INM 0.40
- MACD
- GLMD 0.01
- INM 0.11
- Stochastic Oscillator
- GLMD 69.77
- INM 37.04
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.